The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Purifloh (PO3) Chairman Bill Parfet has announced his resignation from the head position and as the company’s Director of the Board
  • The former Chairman announced the news this morning, stating the resignation was effective immediately
  • Bill has thanked the company for the opportunity but is focused on spending more time with his family in retirement
  • Purifloh Director Carl Le Souef will step into the Chairman role on an interim basis
  • Shares in Purifloh have opened trading down 21.1 per cent for $1.50

Purifloh (PO3) Chairman, Bill Parfet, has announced his resignation from the Chairman position and stepped down as the Director of the Board.

In a statement, Bill thanked the company for the opportunity and said he had decided to spend more time with his family in retirement.

“It has been an honour to lead Purifloh over the past 12 months though I now wish to spend more time in retirement with my family,” he said.

“I depart with nothing but good wishes and best regards for the company, my fellow Board Members and the management team,” he added.

The former Chairman will retain his shareholding in Purifloh and has offered his continued support to the company.

Bill will be replaced by current Purifloh Director Carl Le Souef, who will step into the Chairman role on an interim basis.

Carl also controls the company’s major shareholder, the business Dilato Holdings.

“All shareholders owe a debt of gratitude towards Bill for his investment in Purifloh, together with his efforts on behalf of the company,” the new interim Chairman said.

“We thank Bill for his support and leadership and wish him the very best in his retirement,” he added.

The director also promised to release another update on Purifloh’s activities soon, with the company announcing its annual report yesterday.

The company, which creates technology for purifying air, water and surfaces, announced the leadership news before market open on Friday.

Shares in the company have since dropped as investors react, trading down 21.1 per cent, with shares worth $1.50 at 10:38 am AEST.

PO3 by the numbers
More From The Market Online
Image of a woman holding a bottle of hemp oil

Little Green Pharma jumps into distribution with acquisition

Little Green Pharma is aiming to make the strategic acquisition of HH (Australia) Pty Ltd to…
Image of cancer cells

Radiopharm approved to start Lu-RAD202 safety trials, door open for in-human studies

Radiopharm Theranostics has received ethics approval for its trial into Lu-RAD202, a novel treatment for these…
Close up of a nasal spray

LTR Pharma pairs with Men’s Health Downunder for supply of erectile dysfunction spray

LTR Pharma Ltd has signed an agreement with Men's Health Downunder to facilitate supply of its…
Immune system concept ai gen

Immutep dips as safety test for flagship drug IMP761 shows no adverse effects

Immutep has reported a small-scale conceptual safety test among 5 patients using flagship drug IMP761 has…